Merck Vows To Be In Top Five In India By 2015; Push Will Come From 13 New Launches In The Next Two Years
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Buoyed by strong performance of its key brands Januvia (sitagliptin) and Gardasil launched last year in India, U.S. drug giant Merck is going full throttle in its ambition to figure in the top five companies in India by 2015